THE PLACE OF ANTIPLATELET AGENTS IN THE SECONDARY PREVENTION OF ISCHEMIC STROKE IN CHILDREN AND YOUNG PATIENTS


O.A. Lvova, V.V. Gusev

Department of Pediatric Neurology and Neonatology SBEI HPE «Ural State Medical University" of RMPH, Ekaterinburg
The article describes the current data and debating points on the indications, dosage and duration of therapy with aspirin and clopidogrel in stroke young patients and children. Recommended dosage for children is 1-3 for aspirin and 0.2-2.0 mg/kg/day for clopidogrel. The authors provide their own data on the six-year follow-up of 82 children with acute ischemic cerebrovascular insufficiency, who received antithrombotic therapy. The high efficiency (twofold reduction of recurrence of thrombotic events) and safety of the proposed scheme for medical support of patients is demonstrated.

About the Autors


O.A. Lvova – PhD in Medical Sciences, Associate Professor, Head of the Department of Pediatric Neurology and Neonatology SBEI HPE «Ural State Medical University" of RMPH; e-mail: RFolvova @ bk.ru
V.V. Gusev - PhD in Medical Sciences, Head of the Neurological Department MBHCI CCCH № 23, Teaching Assistant at the Department of Pediatric Neurology and Neonatology SBEI HPE «Ural State Medical University" of RMPH; e-mail: gusev_vadim@inbox.ru


Similar Articles


Бионика Медиа